Scaling TB Diagnosis: The Shift Toward Pooled Testing
The landscape of tuberculosis (TB) detection is undergoing a significant transformation. For years, the challenge has been reaching the “missed millions”—individuals who remain undiagnosed and untreated, continuing the cycle of transmission.
A pivotal shift is now occurring through the implementation of pooled sputum testing. Evidence from the Start4All partnership, led by the Liverpool School of Tropical Medicine (LSTM), demonstrates that pooling samples can significantly cut costs and expand diagnostic access without compromising the accuracy of the results.
This approach allows healthcare providers to screen more people using fewer resources, making it a viable strategy for regions where laboratory capacity is limited and patient volumes are high.
Integrating Global Guidelines into Local Action
The transition from research to real-world application is driven by the alignment of evidence and policy. The findings from Start4All have directly informed the World Health Organization (WHO) 2026 pooled sputum testing guidelines.
By translating these guidelines into a practical, open-access toolkit, National TB Programmes can now implement and scale up pooled testing with a standardized framework. This ensures that the move toward more efficient testing is sustainable and equitable across different healthcare settings.
Closing the Gap for the ‘Missed Millions’
To eliminate TB, diagnosis must move beyond centralized hospitals and into the heart of the communities most affected. The goal is to bring rapid TB testing closer to the people, reducing the barriers to entry for those in remote or underserved areas.
This strategy is particularly critical for high-burden populations, including those with HIV-associated TB and those facing drug-resistant TB. By identifying these cases earlier, healthcare systems can ensure a faster linkage to quality care and treatment.
The Start4All project focuses its efforts on seven partner countries identified by the WHO as having high TB burdens: Bangladesh, Brazil, Cameroon, Kenya, Malawi, Nigeria, and Vietnam.
The Future of Sustainable TB Infrastructure
The long-term trend in TB control is the movement toward scalability and sustainability. By utilizing combination diagnostic test packages and pooled testing, health systems can create better use of limited resources.
Collaborations between lead organizations like LSTM, global health advocacy partners such as Unitaid and StopTB, and evaluation partners like FIND are essential. These multi-partner collaborations help close the diagnostics gap and strengthen national healthcare partnerships.
As these innovative approaches become standard, the focus will likely shift toward expanding coverage and ensuring that affordable, equitable healthcare is available to every single person affected by the disease.
Frequently Asked Questions
We see a diagnostic approach where multiple samples are grouped together for testing. If a pool tests negative, all samples in that pool are cleared; if positive, individual samples are tested. This method cuts costs and expands access without compromising accuracy.
The project is led by the Liverpool School of Tropical Medicine (LSTM) and is funded by Unitaid.
The project operates in seven high TB burden countries: Bangladesh, Brazil, Cameroon, Kenya, Malawi, Nigeria, and Vietnam.
The toolkit provides practical, open-access tools based on WHO guidelines to help programs implement or scale up pooled testing, bringing diagnosis closer to communities.
Want to stay updated on the latest breakthroughs in global health? Share your thoughts on the future of TB diagnostics in the comments below or subscribe to the Global TB Community Advisory Board newsletter for weekly updates.
